Priothera Receives R&D Innovation Loan from Bpifrance
€1.5 million loan will further support clinical manufacture of mocravimod for the adjunctive treatment of Acute Myeloid Leukemia (AML) DUBLIN and SAINT-LOUIS, France, April 4, 2022
Source: finanznachrichten.de